MEDTOX SCIENTIFIC INC 4
4 · MEDTOX SCIENTIFIC INC · Filed Apr 4, 2012
Insider Transaction Report
Form 4
SCHOONOVER JAMES A
Vice President and CMO
Transactions
- Award
Common Stock
2012-04-03$17.37/sh+16,522$286,987→ 130,728 total - Award
Common Stock
2012-04-03$17.37/sh+1,295$22,494→ 132,023 total
Footnotes (2)
- [F1]Shares are attributable to a performance based non-qualified deferred compensation plan and are subject to vesting and a substantial risk of forfeiture. Shares have been acquired either in a private transaction or in the open market and are exempt under Rule 16b-3.
- [F2]Shares are attributable to a non-qualified deferred compensation plan and are subject to vesting and a substantial risk of forfeiture. Shares have been acquired either in a private transaction or in the open market and are exempt under Rule 16b-3.